ACYCLOVIR 400 MG TABLET
For 30 tablets
Pharmacies pay
$2.89 filed
30 × $0.09623 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$8.32 estimated
$2.89 + $0.43 (15%) + $5.00 fee per fill = $8.32
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
ACYCLOVIR 400 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as acyclovir.
FDA gives its dosage form as tablet and its route as oral.
FDA lists 11 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. and Camber Pharmaceuticals, Inc.
FDA lists it under 3 Established Pharmacologic Classes: Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor and Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor.
The NADAC file of 2026-10-14 prices it under 21 NDCs (National Drug Codes); the FDA directory lists 19 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $2.89 for 30 tablets (30 × $0.09623 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 11 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| American Health Packaging | 2 | $0.09623 per EA filed |
| Aurobindo Pharma Limited | 2 | $0.09623 per EA filed |
| Bionpharma Inc. | 2 | $0.09623 per EA filed |
| Camber Pharmaceuticals, Inc. | 2 | $0.09623 per EA filed |
| Carlsbad Technology, Inc. | 2 | $0.09623 per EA filed |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2 | $0.09623 per EA filed |
| Westminster Pharmaceuticals, LLC | 2 | $0.09623 per EA filed |
| Zydus Pharmaceuticals (USA) Inc. | 2 | $0.09623 per EA filed |
| Apotex Corp. | 1 | $0.09623 per EA filed |
| AvPAK | 1 | $0.09623 per EA filed |
| Major Pharmaceuticals | 1 | $0.09623 per EA filed |
| Not listed as a package in the FDA directory | 2 | $0.09623 per EA filed |
All 21 NDCs, with labeler and price
- 00904-7507-61 · Major Pharmaceuticals · $0.09623 per EA · eff. 2026-09-23 filed
- 23155-0227-01 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.09623 per EA · eff. 2026-09-23 filed
- 23155-0227-05 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.09623 per EA · eff. 2026-09-23 filed
- 31722-0777-01 · Camber Pharmaceuticals, Inc. · $0.09623 per EA · eff. 2026-09-23 filed
- 31722-0777-05 · Camber Pharmaceuticals, Inc. · $0.09623 per EA · eff. 2026-09-23 filed
- 50268-0061-11 · not listed as a package in the FDA directory · $0.09623 per EA · eff. 2026-09-23 filed
- 50268-0061-15 · AvPAK · $0.09623 per EA · eff. 2026-09-23 filed
- 59651-0965-01 · Aurobindo Pharma Limited · $0.09623 per EA · eff. 2026-09-23 filed
- 59651-0965-05 · Aurobindo Pharma Limited · $0.09623 per EA · eff. 2026-09-23 filed
- 60505-5306-01 · Apotex Corp. · $0.09623 per EA · eff. 2026-09-23 filed
- 60687-0856-01 · American Health Packaging · $0.09623 per EA · eff. 2026-09-23 filed
- 60687-0856-11 · not listed as a package in the FDA directory · $0.09623 per EA · eff. 2026-09-23 filed
- 60687-0856-65 · American Health Packaging · $0.09623 per EA · eff. 2026-09-23 filed
- 61442-0112-01 · Carlsbad Technology, Inc. · $0.09623 per EA · eff. 2026-09-23 filed
- 61442-0112-05 · Carlsbad Technology, Inc. · $0.09623 per EA · eff. 2026-09-23 filed
- 68382-0791-01 · Zydus Pharmaceuticals (USA) Inc. · $0.09623 per EA · eff. 2026-09-23 filed
- 68382-0791-05 · Zydus Pharmaceuticals (USA) Inc. · $0.09623 per EA · eff. 2026-09-23 filed
- 69367-0137-01 · Westminster Pharmaceuticals, LLC · $0.09623 per EA · eff. 2026-09-23 filed
- 69367-0137-05 · Westminster Pharmaceuticals, LLC · $0.09623 per EA · eff. 2026-09-23 filed
- 69452-0290-20 · Bionpharma Inc. · $0.09623 per EA · eff. 2026-09-23 filed
- 69452-0290-30 · Bionpharma Inc. · $0.09623 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
5 other products in the NADAC file share the FDA nonproprietary name acyclovir with ACYCLOVIR 400 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| ACYCLOVIR 5% CREAM | $8.99159 per GM filed | We don’t know yet |
| ACYCLOVIR 5% OINTMENT | $0.34585 to $0.52214 per GM filed | We don’t know yet |
| ACYCLOVIR 200 MG CAPSULE | $0.09773 per EA filed | We don’t know yet |
| ACYCLOVIR 200 MG/5 ML SUSP | $0.07643 per ML filed | We don’t know yet |
| ACYCLOVIR 400 MG TABLET this page | $0.09623 per EA filed | We don’t know yet |
| ACYCLOVIR 800 MG TABLET | $0.19403 per EA filed | We don’t know yet |
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17
Compared with its class
The middle of its 21 NDCs’ NADAC prices is $0.09623 per EA filed.
Of the 6 other products in FDA’s Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor class priced per EA, 6 have a higher middle NADAC price and 0 a lower one. The one in the middle is VALACYCLOVIR HCL 500 MG TABLET, at $0.22889 per EA filed (eff. 2026-09-23).
Of the 6 other products in FDA’s Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor class priced per EA, 6 have a higher middle NADAC price and 0 a lower one. The one in the middle is VALACYCLOVIR HCL 500 MG TABLET, at $0.22889 per EA filed (eff. 2026-09-23).
Of the 9 other products in FDA’s Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor class priced per EA, 9 have a higher middle NADAC price and 0 a lower one. The one in the middle is VALACYCLOVIR HCL 1 GRAM TABLET, at $0.41001 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Related pages
Its pharmacologic classes
- Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor
- Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor
- Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor